{"id":"https://openalex.org/W2510856830","doi":null,"title":"ENHANCED SENSITIVITY OF SOFT TISSUE SARCOMA TO TRAIL MEDIATED APOPTOSIS","display_name":"ENHANCED SENSITIVITY OF SOFT TISSUE SARCOMA TO TRAIL MEDIATED APOPTOSIS","alternate_titles":[],"publication_year":2002,"publication_date":"2002-11-01","ids":{"openalex":"https://openalex.org/W2510856830","mag":"2510856830"},"language":"en","primary_location":{"id":"mag:2510856830","doi":null,"is_oa":false,"landing_page_url":"https://online.boneandjoint.org.uk/doi/10.1302/0301-620X.84BSUPP_III.0840217c","pdf_url":null,"source":{"id":"https://openalex.org/S4387287184","display_name":"Orthopaedic Proceedings","issn_l":"1358-992X","issn":["1358-992X","2049-4416"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Orthopaedic Proceedings","raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W2510856830"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075623882","display_name":"Andreas Evdokiou","orcid":"https://orcid.org/0000-0001-8321-9806","observed_orcids":["https://orcid.org/0000-0001-8321-9806"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andreas Evdokiou","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8321-9806","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037104741","display_name":"Mark Clayer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark Clayer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5113563818","display_name":"D. Findlay","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. Findlay","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"217","last_page":"217"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.9047999978065491,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.9047999978065491,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.08829999715089798,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trail","display_name":"TRAIL","score":0.9459999799728394},{"id":"https://openalex.org/keywords/apo2l","display_name":"Apo2L","score":0.8790000081062317},{"id":"https://openalex.org/keywords/soft-tissue-sarcoma","display_name":"soft tissue sarcoma","score":0.9380000233650208},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.8349999785423279},{"id":"https://openalex.org/keywords/chemosensitization","display_name":"chemosensitization","score":0.7429999709129333},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.7850000262260437},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.6179999709129333},{"id":"https://openalex.org/keywords/decoy-receptor","display_name":"decoy receptor","score":0.777999997138977},{"id":"https://openalex.org/keywords/tumor-necrosis","display_name":"tumor necrosis","score":0.6830000281333923},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.5799999833106995}],"concepts":[{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.7245886921882629},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.635064423084259},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6171929240226746},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5542610287666321},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.5402599573135376},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.5293396711349487},{"id":"https://openalex.org/C2778256501","wikidata":"https://www.wikidata.org/wiki/Q223911","display_name":"Sarcoma","level":2,"score":0.5225733518600464},{"id":"https://openalex.org/C2778629024","wikidata":"https://www.wikidata.org/wiki/Q720020","display_name":"Soft tissue sarcoma","level":3,"score":0.4879738688468933},{"id":"https://openalex.org/C503630168","wikidata":"https://www.wikidata.org/wiki/Q178069","display_name":"Necrosis","level":2,"score":0.48765313625335693},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.4856621026992798},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.48440009355545044},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4536267817020416},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.43380624055862427},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.30491459369659424},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.28176116943359375},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2738773822784424},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2629013657569885},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.16393345594406128},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.13656464219093323},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2510856830","doi":null,"is_oa":false,"landing_page_url":"https://online.boneandjoint.org.uk/doi/10.1302/0301-620X.84BSUPP_III.0840217c","pdf_url":null,"source":{"id":"https://openalex.org/S4387287184","display_name":"Orthopaedic Proceedings","issn_l":"1358-992X","issn":["1358-992X","2049-4416"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Orthopaedic Proceedings","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1519814596","https://openalex.org/W1993300838","https://openalex.org/W2108371361","https://openalex.org/W1439244150","https://openalex.org/W2000902965","https://openalex.org/W2029454833","https://openalex.org/W2078747183","https://openalex.org/W2026361207","https://openalex.org/W1560704839","https://openalex.org/W1594540235"],"abstract_inverted_index":{"TRAIL/Apo2L":[0],"is":[1,27],"a":[2,76,119,199],"member":[3],"of":[4,11,16,64,73,113,202],"the":[5,70,111,149,162,176],"tumour":[6,155],"necrosis":[7,156,171],"factor":[8],"(TNF)":[9],"family":[10],"cytokines":[12],"that":[13,92,185],"induces":[14],"death":[15,33,55],"cancer":[17],"cells":[18,194],"but":[19],"not":[20,59],"normal":[21],"cells.":[22],"Its":[23],"potent":[24],"apoptotic":[25],"activity":[26,72],"mediated":[28],"through":[29],"its":[30],"cell":[31,120,123],"surface":[32],"domain":[34],"containing":[35],"receptors,":[36,46],"DR4":[37],"and":[38,49,57,115,139,141,157,187,195],"DR5.":[39],"TRAIL":[40,74,147,188],"binds":[41],"also":[42],"to":[43,68,96,103,106,117,169,191],"three":[44],"\u201cdecoy\u201d":[45],"DcR1,":[47],"DcR2":[48],"osteoprotegerin":[50],"(OPG),":[51],"which":[52],"lack":[53],"functional":[54],"domains,":[56],"do":[58],"induce":[60],"apoptosis.":[61],"The":[62],"aim":[63],"this":[65,158],"study":[66],"was":[67,125,159,172],"investigate":[69],"cytotoxic":[71,203],"as":[75],"single":[77],"agent":[78,180],"or":[79],"in":[80,142,161],"combination":[81],"with":[82,174],"clinically":[83],"relevant":[84],"anti-sarcoma":[85],"drugs":[86],"on":[87],"human":[88],"soft":[89,99],"tissue":[90,100],"sarcomas":[91,101],"are":[93],"traditionally":[94],"resistant":[95,105],"chemotherapy.":[97],"Human":[98],"known":[102],"be":[104],"chemotherapy":[107,186],"were":[108],"taken":[109],"at":[110],"time":[112],"biopsy":[114],"cultured":[116],"produce":[118],"line.":[121],"This":[122],"line":[124],"then":[126],"tested":[127],"against":[128],"TRAIL,":[129],"standard":[130,150],"chemotherapeutic":[131,151,179],"agents":[132,152],"(including":[133],"doxorubicin,":[134],"cis":[135],"platinum,":[136],"etoposide,":[137],"methotrexate":[138],"cyclophosphamide)":[140],"combination.":[143],"When":[144],"used":[145],"alone,":[146],"and/or":[148],"produced":[153],"minimal":[154],"mirrored":[160],"clinical":[163],"results.":[164],"In":[165],"combination,":[166],"however,":[167],"up":[168,198],"60%":[170],"seen,":[173],"doxorubicin":[175],"most":[177],"effective":[178],"used.":[181],"These":[182],"results":[183],"indicate":[184],"act":[189],"synergistically":[190],"kill":[192],"sarcoma":[193],"potentially":[196],"opens":[197],"new":[200],"area":[201],"treatment":[204],"for":[205],"these":[206],"difficult":[207],"malignancies.":[208]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2510856830","counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2016-09-16T00:00:00"}
